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BACKGROUND
• Osteocytes
• Osteocytes are terminally differentiated osteoblasts embedded in the 
bone matrix 
• Roles in mechanosensation, and possible role in phosphate 
homeostasis
• Osteocyte ablation results in osteoporosis (Tatsumi et al. 2007)
• Sclerostin/SOST & Osteocytes
• Osteocytes control osteoblast differentiation and activation through 
the Sclerostin-Wnt signaling pathway
• Future Targeted Treatment Options: Mature osteocytes are the only 
cells in the adult human known to express sclerostin, the protein 
product of the gene SOST.  
• Hindlimb unloading in mice dramatically upregulates SOST/Sclerostin 
expression by osteocytes (Robling et al., 2008)
• SOST -/- null mice are fully resistant to hindlimb induced bone loss 
(Lin, C, et al., 2009)
• PTH suppresses SOST expression (Bellido et al., 2005)
INTRODUCTION
Osteocyte cells are the most abundant (90%) yet least understood
bone cell type in the human body. Osteocytes are theorized to be the
mechanosensors and transducers of mechanical load for bones, yet
the biological mechanism of this action remains elusive. However,
recent discoveries in osteocyte cell biology have shed light on their
importance as key mechanosensing cells regulating bone
remodeling and phosphate homeostasis.
The aim of this project was to characterize gene expression
patterns and protein levels following exposure of MLO-Y4, a
very well characterize murine osteocyte-like cell line, to
simulated microgravity using the NASA Rotating Wall Vessel
(RWV) Bioreactor.
To determine mechanistic pathways of the osteocyte’s gravity
sensing ability, we evaluated in vitro gene and protein expression of
osteocytes exposed to simulated microgravity.
Improved understanding of the fundamental mechanisms of
mechanotransduction at the osteocyte cellular level may lead to
revolutionary treatment options to mitigate the effects of bone
loss encountered by astronauts on long duration space
missions and provide tailored treatment options for maintaining
bone strength of immobilized/partially paralyzed patients here
on Earth.
Figure 2: MLO-Y4 Osteocytic cells subjected to simulated
microgravity: MLO-Y4 cells were grown on 3D collagen scaffold and
subjected to static (A and C) or dynamic (B and D) culture conditions. H&E
staining (A and B) showed increase in cell proliferation in MLO-Y4 cultured
under dynamic vertical bioreactor condition (rotating bioreactor, panel B).
Immunohistochemistry for Sclerostin (C and D) showed an increase in
Sclerostin expression (black staining) in MLO-Y4 grown under dynamic
vertical (simulated microgravity) bioreactor condition (panel D).
Figure 3: Unloading causes characteristic osteocyte
morphologic changes: Osteocytes from immobilized rat (A and C,
Krempien, 1976) and MLO-Y4 cultured on 3D collagen scaffold under
simulated microgravity (B and D, H&E staining). Loaded osteocytes are
spindle-shaped with small nuclei; unloaded osteocytes have enlarged
round nuclei and cytoplasms.
MATERIAL & METHODS
Cells. MLO-Y4 cells were grown to confluence, harvested and seeded onto 3D
collagen scaffold (BD) at a concentration of 250,000 cells/scaffold. Scaffolds (4 per
condition) were either rotated in a vertical 50ml NASA/bioreactor vessel at a speed of
18 rpm (simulated microgravity), cultured in a horizontal 50 ml NASA bioreactor vessel
at a speed of 18 rpm (control for the increased sheared environment of rotating
vessel), or cultured into a static T-75 cm dish (static condition) at the laboratories of
the National Space and Aeronautics Administration (NASA) Johnson Spaceflight
Center (JSC).
Histology and immunohistochemistry. Scaffolds were either frozen with OCT or
fixed in 10% formalin/PBS solution at 4 C ON, sectioned, processed and stained.
Sections were stained with H&E or used for immunohistochemistry
Quantitative RT-PCR
Reverse transcription was performed on 1 µg of total RNA and semi quantitative RT-
PCR was performed using the QuantiTect SYBR Green PCR Kit (QIAGEN) and the
DNA Engine Opticon 2 qPCR system (MJ Research Inc.) according to the
manufacturers’ instructions.
Figure 5: Sclerostin protein expression up-regulated @ 21
days: Sclerostin expression in MLO-Y4 cultured on 3D scaffold for 21 days
under static (A), increased sheared environment (horizontal rotating
bioreactor), (B), or simulated microgravity (vertical rotating bioreactor), (C).
Figure 4: Simulated microgravity increases SOST
expression @ 7 days: Real-time qPCR for SOST mRNA in
MLO-Y4 cells cultured with mechanical stimulation alone (HRB) or in
combination with simulated microgravity (VBR) for 7 days.
Stimulated microgravity induced a 7 fold increase in SOST mRNA
expression. Results are expressed as relative RNA and are
normalized by GAPDH. Data are expressed as mean ± SD of
triplicates. Experiments were repeated twice.
*
Conclusions
•Simulated Microgravity in-vitro causes:
• Osteocyte morphologic changes similar to immobilization
unloading
•Increases in SOST & Sclerostin expression relative to rotating
control
• Decreases Connexin-43 expression
• NASA/RWV mimics unloading to produce predictable regulation of
known osteocyte mechanotransduction pathways at the molecular-cellular
level. Future flight studies onboard ISS are needed for validation.
• NASA/RWV in-vitro osteocyte model allows future studies to investigate
mechanotransduction pathways difficult to impossible to be conducted in-
vivo
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Figure 6: Simulated microgravity decreases Cnx43
expression @ 21 days: Real-time qPCR for Cnx43 mRNA in MLO-Y4
cells cultured with mechanical stimulation alone (HBR) or in combination with
simulated microgravity (VBR) for 7 & 21 days. Stimulated microgravity
induced a 40% decrease in Cnx43 mRNA expression. Results are expressed
as relative RNA and are normalized by GAPDH. Mechanical stimulation has
been shown previously to increase Cnx43 expression. Data are expressed as
mean ± SD of triplicates. Experiments were repeated twice
Figure 1: Scerlostin Mechanism of Action: Differentiation and
osteoblasts activation mediated by Sclerostin/Wnt signaling pathway
(adapted from Bilezikian et al., 2002)
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